Axim Biotechnologies, Inc. 

CA

  SEC # 1514946

        

Click to view...

Registrant

About

Filings

Files

Relationships

Names

Topics

Web

Registrant
 SEC-Registered:  3/9/11   —   First EDGAR Filing:  3/10/11   –   Last Filing:  4/16/24 

Business Address      On:  4/16/24       [ Map ]		Mailing Address      On:  4/16/24       [ Map ]
6191 Cornerstone Court, E Suite 114 San Diego, California  92121 U.S.A.

Phone #		Organized In		Fiscal-Year End		IRS #		SEC CIK		SEC File #
+1 212-751-0001		Nevada, U.S.A.		12/31/yy		27-4092986		0001514946		000-54296

Market: Symbol:  OTC: AXIM

Industry Classification
SIC:     Code      U.S. Industry      Through      Source      Filings-Review Office 2834 Pharmaceutical Preparations 2024 SEC Office of Life Sciences 4953 Refuse Systems 2015 SEC Office of Energy & Transportation 6770 Special-Purpose Acquisition Companies (SPACs), a.k.a. Blank Checks, et al. 2014 SEC Office of Real Estate & Construction

        

Management
Director   In   NY   Cunningham Robert L 2017-2024   CA   Huemoeller John Walter II 2017-2024   NY   Schroeder Blake 2017-2024   NY   Scott Timothy Richard 2017-2024   NY   O’Rourke Peter 2022-2024 ↓List Pre-2020 Directors				Officer  Since  Most-Recent Title   In   CA   Huemoeller John Walter II 2022 Chief Executive Officer 2024   CA   Malasek Robert 2017 Chief Financial Officer 2024   FL   Phinney Kurt Chief Operating Officer 2023 ↓List Pre-2020 Officers

        

        

        

        

Securities
Market:  Symbol       (Prices)   OTC:  AXIM   _________  Symbol source:  SEC  As of:  4/25/24		CUSIP, CINS or PPN       Description ← Symbol   Issuer Issue (Class or re: Filing — Name)      To 2024:   05463V 05463V·10·0     Stock _________  Classes source:  Form 13F Filings that list Section 13(f) Securities